ABSTRACT
Background Pulmonary rehabilitation(PR) is a highly effective intervention for people with chronic respiratory disease, however it is not known how best to sustain its benefits. Clinical trials are needed to establish if participation in Singing for Lung Health(SLH) groups following PR will improve health-related quality-of-life, healthcare utilisation and exercise capacity compared to usual care. A feasibility study would help to guide development of these.
Methods In a multi-centre, mixed-methods randomised controlled feasibility trial, PR participants at 4 sites, were pre-screened at baseline assessment. An SLH taster session was included routinely as part of the PR programmes. Eligible PR completers were invited to take part in the trial and randomised to usual care or a 12-week SLH course. Feasibility outcomes included recruitment rate, intervention compliance (at least 8/12 sessions) and completeness of data collection including symptom questionnaires, walk tests and physical activity monitoring. Interviews with participants and study personnel about their experience and views of the study were subjected to thematic analysis.
Results Between October 2022 and November 2023, 1311 patients were assessed to start PR, 838 completed. Of those completing, 243 were ineligible to take part, (predominantly due to vaccination status and other primary PR diagnoses), and 531 declined. 64 people (33 female, mean(SD) age 69(12), 41 ethnically white, COPD/asthma/interstitial lung disease/bronchiectasis n=33/16/9/6) were recruited with 30(93.8%) SLH and 29(90.6%) controls completing the study. 20(62.5%) of the SLH group completed at least 8/12 SLH sessions. There was enthusiasm for a definitive trial from participants, clinicians and singing group leaders perspectives based on positive experiences of trial involvement. Improvements to recruitment strategy, intervention structure, outcome measures and staffing were suggested.
Conclusion A definitive RCT of SLH post-PR appears feasible, with acceptable uptake and completion rates.
Trial Registration ISRCTN11056049
What is already known on this topic?Singing for Lung Health(SLH) has previously been shown to improve health-related quality-of-life for people with Chronic Obstructive Pulmonary Disease. Pulmonary Rehabilitation is a gold standard intervention, but it is not known whether SLH groups can be delivered as a maintenance programme after PR completion, or whether an RCT comparing this approach to usual care is feasible.
What this study adds It is feasible to conduct an RCT investigating the clinical and cost effectiveness of a 12-week SLH post PR maintenance programme compared with usual care.
How this might affect research, practice or policy This study will inform the design and delivery of a definitive RCT. The feasibility methodology used in this study can be applied to other creative health interventions which may be considered as maintenance options post-PR.
Competing Interest Statement
CMN reports grants from the National Institute for Health and Care Research, outside the submitted work. All other authors declare no conflicts of interest
Clinical Trial
ISRCTN11056049
Funding Statement
This project was funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number NIHR201539). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by Hampshire Research Ethics Committee B reference 21/SC/0240 IRAS number: 293580. 01/10/2021.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This project was funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number NIHR201539). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
COI CMN reports grants from the National Institute for Health and Care Research, outside the submitted work. All other authors declare no conflicts of interest.
Data Sharing Statement Data sharing may occur on reasonable request
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos